Jefferies Financial Group Inc. Buys Shares of 25,537 LeMaitre Vascular, Inc. $LMAT

Jefferies Financial Group Inc. bought a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) in the second quarter, Holdings Channel reports. The firm bought 25,537 shares of the medical instruments supplier’s stock, valued at approximately $2,451,000.

A number of other hedge funds have also modified their holdings of the company. Kennedy Capital Management LLC raised its holdings in LeMaitre Vascular by 14.8% in the fourth quarter. Kennedy Capital Management LLC now owns 247,907 shares of the medical instruments supplier’s stock worth $20,105,000 after purchasing an additional 32,040 shares during the period. Wakefield Asset Management LLLP acquired a new position in shares of LeMaitre Vascular during the fourth quarter worth about $1,130,000. Riverbridge Partners LLC bought a new position in shares of LeMaitre Vascular during the 1st quarter worth approximately $11,528,000. Vanguard Group Inc. increased its stake in LeMaitre Vascular by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,622,033 shares of the medical instruments supplier’s stock valued at $131,547,000 after buying an additional 21,946 shares during the last quarter. Finally, Conestoga Capital Advisors LLC raised its holdings in LeMaitre Vascular by 3.6% during the first quarter. Conestoga Capital Advisors LLC now owns 1,476,813 shares of the medical instruments supplier’s stock worth $161,224,000 after acquiring an additional 51,825 shares in the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Weiss Ratings cut shares of LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, August 14th. Wells Fargo & Company dropped their target price on LeMaitre Vascular from $104.00 to $94.00 and set an “equal weight” rating for the company in a report on Wednesday, August 5th. Wall Street Zen cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Citizens Jmp boosted their target price on shares of LeMaitre Vascular from $118.00 to $127.00 and gave the company a “market outperform” rating in a research report on Wednesday, May 6th. Finally, Citigroup reissued a “market outperform” rating on shares of LeMaitre Vascular in a report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $110.60.

LeMaitre Vascular Stock Performance

Shares of LeMaitre Vascular stock opened at $80.45 on Friday. The company’s fifty day moving average is $93.04 and its 200 day moving average is $99.32. LeMaitre Vascular, Inc. has a twelve month low of $78.27 and a twelve month high of $118.01. The stock has a market cap of $1.84 billion, a price-to-earnings ratio of 28.23, a P/E/G ratio of 2.32 and a beta of 0.53. The company has a quick ratio of 13.96, a current ratio of 16.31 and a debt-to-equity ratio of 0.40.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.07). LeMaitre Vascular had a return on equity of 15.63% and a net margin of 25.02%.The company had revenue of $70.38 million for the quarter, compared to the consensus estimate of $71.47 million. During the same quarter last year, the business earned $0.60 earnings per share. LeMaitre Vascular’s revenue was up 9.6% compared to the same quarter last year. Sell-side analysts forecast that LeMaitre Vascular, Inc. will post 2.89 EPS for the current year.

LeMaitre Vascular Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th will be given a $0.25 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $1.00 annualized dividend and a dividend yield of 1.2%. LeMaitre Vascular’s dividend payout ratio (DPR) is 35.09%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.